Nephrocare Health Services’ share price target is a subject of steady discussion among investors, as the company is a strong healthcare player in dialysis and renal care services. Due to the increasing number of chronic kidney disease cases in India, the aging population, and growing insurance penetration, Nephrocare Health Services long term growth outlook appears quite positive.
Nephrocare Health Services current market price is ₹438, and the company is expanding its dialysis center network especially in Tier 2 and Tier 3 cities. The asset light expansion model, improving occupancy rates, and long term hospital partnerships clearly indicate that Nephrocare Health Services share price target can show stable and sustainable growth in the coming years.
Nephrocare Health Services Share Price Target 2025
The Nephrocare Health Services share price target could be in the range of ₹470-₹495 by the end of 2025. Due to center expansion and steady patient inflow, the Nephrocare Health Services share price target may see a gradual upward movement in 2025.
| Month | Expected Price (INR) |
|---|---|
| December | ₹470 – ₹495 |
Nephrocare Health Services Share Price Target 2026
The Nephrocare Health Services share price target could reach ₹520-₹560 in 2026. Expansion of insurance coverage, higher dialysis sessions, and improved operational efficiency will support the company’s margins. Therefore, there are chances of a steady compounding phase for the Nephrocare Health Services share price target in 2026.
| Month | Expected Price (INR) |
|---|---|
| January | ₹495 – ₹505 |
| February | ₹500 – ₹510 |
| March | ₹505 – ₹515 |
| April | ₹510 – ₹520 |
| May | ₹515 – ₹525 |
| June | ₹520 – ₹530 |
| July | ₹525 – ₹535 |
| August | ₹530 – ₹540 |
| September | ₹535 – ₹545 |
| October | ₹540 – ₹550 |
| November | ₹545 – ₹555 |
| December | ₹550 – ₹565 |
Nephrocare Health Services Share Price Target 2027
The outlook for the Nephrocare Health Services share price target in 2027 becomes even stronger. The company will scale up its dialysis centers and improve patient retention, leading to stronger revenue visibility. This year, the Nephrocare Health Services share price target could touch the ₹600-₹650 range.
| Month | Expected Price (INR) |
|---|---|
| January | ₹565 – ₹580 |
| February | ₹575 – ₹590 |
| March | ₹585 – ₹600 |
| April | ₹595 – ₹610 |
| May | ₹605 – ₹620 |
| June | ₹615 – ₹630 |
| July | ₹625 – ₹640 |
| August | ₹635 – ₹650 |
| September | ₹645 – ₹660 |
| October | ₹655 – ₹670 |
| November | ₹665 – ₹680 |
| December | ₹675 – ₹690 |
Nephrocare Health Services Share Price Target 2028
The Nephrocare Health Services share price target could reach ₹720–₹780 in 2028. By this time, the company’s center network will be quite mature, and margins will also improve. Long term healthcare demand will give strong support to Nephrocare Health Services share price target.
| Month | Expected Price (INR) |
|---|---|
| January | ₹690 – ₹705 |
| February | ₹700 – ₹715 |
| March | ₹710 – ₹725 |
| April | ₹720 – ₹735 |
| May | ₹730 – ₹745 |
| June | ₹740 – ₹755 |
| July | ₹750 – ₹765 |
| August | ₹760 – ₹775 |
| September | ₹770 – ₹785 |
| October | ₹780 – ₹795 |
| November | ₹790 – ₹805 |
| December | ₹800 – ₹815 |
Nephrocare Health Services Share Price Target 2029
Nephrocare Health Services share price target in 2029 could be around ₹840–₹900. Stable cash flows, long-term hospital contracts and increasing dialysis demand will take the company into a predictable growth phase. Nephrocare Health Services share price target 2029 looks attractive for long term investors.
| Month | Expected Price (INR) |
|---|---|
| January | ₹815 – ₹830 |
| February | ₹825 – ₹840 |
| March | ₹835 – ₹850 |
| April | ₹845 – ₹860 |
| May | ₹855 – ₹870 |
| June | ₹865 – ₹880 |
| July | ₹875 – ₹890 |
| August | ₹885 – ₹900 |
| September | ₹895 – ₹910 |
| October | ₹905 – ₹920 |
| November | ₹915 – ₹930 |
| December | ₹925 – ₹940 |
Nephrocare Health Services Share Price Target 2030
Nephrocare Health Services share price target can reach ₹960-₹1,020 in 2030. Healthcare infra expansion, chronic care demand and operational leverage make Nephrocare Health Services share price target a long term compounding opportunity.
| Month | Expected Price (INR) |
|---|---|
| January | ₹940 – ₹955 |
| February | ₹950 – ₹970 |
| March | ₹960 – ₹980 |
| April | ₹970 – ₹990 |
| May | ₹980 – ₹1,000 |
| June | ₹990 – ₹1,010 |
| July | ₹1,000 – ₹1,020 |
| August | ₹1,010 – ₹1,030 |
| September | ₹1,020 – ₹1,040 |
| October | ₹1,030 – ₹1,050 |
| November | ₹1,040 – ₹1,060 |
| December | ₹1,050 – ₹1,070 |
Conclusion
Overall, Nephrocare Health Services share price target shows a stable and defensive healthcare growth story for long term investors. The journey from ₹438 to ₹1,000 seems realistic if center expansion and patient volumes continue to grow like this. Nephrocare Health Services can be a quality long term compounding opportunity within the healthcare sector.
Disclaimer
This content is for educational & informational purposes only and does not constitute any financial advice.
A stock market enthusiast with hands-on experience in trading. He writes simple and practical content to help people understand the market better.